Breakthrough Infection and Death after COVID-۱۹ Vaccination: A Physics Perspective

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 229

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JBPE-15-3_010

تاریخ نمایه سازی: 29 تیر 1404

چکیده مقاله:

The largest universal immunization in history has occurred as a result of the COVID-۱۹ pandemic. The developed COVID-۱۹ vaccines have been shown to provide protection against severe forms of COVID-۱۹ by inducing anti-spike neutralizing antibodies. It has been found that individuals who have not been vaccinated against COVID-۱۹ were more likely to contract the virus during a period when the Delta variant was dominant, as compared to those who have received the complete dose of the vaccine, irrespective of the variant. However, there is no notable disparity in the likelihood of hospitalization, requirement for mechanical ventilation, or mortality between the two groups once infected. Nevertheless, those who are unvaccinated may require additional oxygen support. There are reports indicating unfavorable health effects, ranging from transient thyroid dysfunction to death following vaccination. In addition, some people are susceptible to SARS-CoV-۲ infection despite they have immunized with the COVID-۱۹ vaccine. Given all these considerations, several key factors should be better understood and considered to enable us to even more successfully manage future pandemics breakthrough infections. The effectiveness of physical treatment methods, e.g., Low Dose Radiation Therapy (LDRT) should be compared to pharmacological treatments.

نویسندگان

Seyed Ali Reza Mortazavi

MVLS College, The University of Glasgow, Glasgow, Scotland, UK

Abdollah Jafarzadeh

Department of Immunology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Abdolkarim Ghadimi-Moghadam

Yasuj University of Medical Sciences, Yasuj, Iran

Seyed Mohammad Javad Mortazavi

Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Masoud Haghani

Department of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

Ali Ghadimi-Moghadam

Faculty of Medicine, Szeged University, Szeged, Hungary

Lembit Sihver

Department of Informatics and Engineering Systems, College of Engineering and Computer Science, University of Texas Rio Grande Valley, TX, USA

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K. Cardiovascular Complications ...
  • Aerts S, Deschrijver D, Joseph W, Verloock L, Goeminne F, ...
  • Keyhani A, Sharifi I, Salarkia E, Khosravi A, Tavakoli Oliaee ...
  • Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO. ...
  • Jafarzadeh A, Nemati M, Jafarzadeh S, Nozari P, Mortazavi SMJ. ...
  • Shafie’ei M, Jamali M, Akbari Z, Sarvipour N, Ahmadzade M, ...
  • Jafarzadeh A, Jafarzadeh S, Pardehshenas M, Nemati M, Mortazavi SMJ. ...
  • Hosseinzadeh A, Sahab-Negah S, Nili S, Aliyari R, Goli S, ...
  • Arora G, Taneja J, Bhardwaj P, Goyal S, Naidu K, ...
  • Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. ...
  • Zimmermann P, Curtis N. Factors That Influence the Immune Response ...
  • Semenzato L, Botton J, Drouin J, Baricault B, Bertrand M, ...
  • Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, ...
  • Lee LYW, Starkey T, Ionescu MC, Little M, Tilby M, ...
  • Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, ...
  • Amanatidou E, Gkiouliava A, Pella E, Serafidi M, Tsilingiris D, ...
  • Kliker L, Zuckerman N, Atari N, Barda N, Gilboa M, ...
  • Van Beusekom M. Vaccines lower risk of long COVID ۱۵%, ...
  • Lee CJ, Woo W, Kim AY, Yon DK, Lee SW, ...
  • Murata K, Nakao N, Ishiuchi N, Fukui T, Katsuya N, ...
  • Oberemok VV, Laikova KV, Yurchenko KA, Fomochkina II, Kubyshkin AV. ...
  • Bevelacqua JJ, Mortazavi SMJ. Don’t worry! The next generation would ...
  • Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, ...
  • Kupferschmidt K. The pandemic virus is slowly mutating. But is ...
  • Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of ...
  • Welsh JS, Bevelacqua JJ, Mozdarani H, Mortazavi SA, Mortazavi SM. ...
  • Rödel F, Arenas M, Ott OJ, Fournier C, Georgakilas AG, ...
  • Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT۳ to ...
  • Calabrese EJ, Dhawan G. How radiotherapy was historically used to ...
  • Schröder S, Kriesen S, Paape D, Hildebrandt G, Manda K. ...
  • Rödel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, ...
  • Yang G, Kong Q, Wang G, Jin H, Zhou L, ...
  • Hekim N, Cetin Z, Nikitaki Z, Cort A, Saygili EI. ...
  • نمایش کامل مراجع